Dentin matrix protein 1 (DMP1), an acidic protein important to the formation of bone and dentin, primarily exists as the processed NH 2 -terminal and COOH-terminal fragments in the extracellular matrix of the two tissues. Previous in vitro studies showed that the substitution of residue Asp 213 by Ala 213 (D213A) at a cleavage site blocked the processing of mouse DMP1 in cells. In this study, we generated transgenic mice expressing mutant D213A-DMP1 (WT/D213A-Tg mice) to test the hypothesis that the proteolytic processing of DMP1 is an activation step essential to osteogenesis. By crossbreeding WT/D213A-Tg mice with Dmp1 knock-out (Dmp1-KO) mice, we obtained mice expressing D213A-DMP1 in a Dmp1-KO background; these mice will be referred to as "Dmp1-KO/ D213A-Tg" mice. Biochemical, radiological, and morphological approaches were used to characterize the skeletal phenotypes of Dmp1-KO/D213A-Tg mice compared with wild-type mice, Dmp1-KO mice, and Dmp1-KO mice expressing the normal Dmp1 transgene. Protein chemistry analyses showed that DMP1 was barely cleaved in the bone of the Dmp1-KO/ D213A-Tg mice, indicating that D213A substitution effectively blocked the proteolytic processing of DMP1 in vivo. While the expression of the normal Dmp1 transgene completely rescued the phenotypic skeletal changes of the Dmp1-KO mice, the expression of the mutant D213A-Dmp1 transgene failed to do so. These results indicate that the fulllength form of DMP1 is an inactive precursor and its proteolytic processing is an activation step essential to the biological functions of this protein in osteogenesis.Dentin matrix protein 1 (DMP1), 2 first identified by cDNA cloning using a rat odontoblast mRNA library, was originally postulated to be dentin-specific (1). Several research groups later demonstrated that DMP1 is also expressed in bone (2, 3, 4) at more abundant levels than in teeth (5,6,7,8). Mouse and human genetic studies have demonstrated that the inactivation of DMP1 leads to osteomalacia/rickets and dentin hypomineralization, indicating that this protein plays crucial roles in osteogenesis and dentinogenesis (9, 10, 11, 12). The major histopathological changes resulting from DMP1-deficiency include an excess accumulation of osteoid in the bone and widening of predentin in the tooth. Although these data have established an association between DMP1 and the formation of healthy mineralized tissues, the exact mechanistic pathways by which this protein participates in vital steps leading to the formation of healthy bone and dentin are unclear.In the extracellular matrix (ECM) of bone and dentin, DMP1 mainly occurs as the proteolytically processed fragments originating from the NH 2 -terminal and COOH-terminal regions of the DMP1 amino acid sequence, respectively (7). The NH 2 -terminal fragment of DMP1 (designated as "DMP1-N") exists in two forms: the 37-kDa fragment (7) and the proteoglycan form referred to as "DMP1-PG" (13), while the COOH-terminal fragment (designated as "DMP1-C") is present as the 57-kDa fragment (7). DMP1-PG cont...